Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ExoSCRT Exosome
- Development stage
- Unknown
- Lead developer
- ExoCoBio
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Topical, Intradermal, Subcutaneous
01
Overview
ExoSCRT Exosome is a proprietary exosome-based biologic product developed by the South Korean biotechnology company ExoCoBio. The product consists of high-purity, nano-sized extracellular vesicles (30-200nm) isolated from stem cell conditioned media using a patented purification technology. These exosomes contain a complex cargo of approximately 1,000 proteins, 600 types of miRNAs, and 400 types of lipids, which facilitate intercellular communication and tissue regeneration. ExoSCRT is being developed for both regenerative aesthetics, such as skin rejuvenation and hair restoration, and therapeutic applications for inflammatory conditions including atopic dermatitis and SARS-CoV-2-related inflammation. The mechanism of action involves promoting ceramide biosynthesis to restore the skin barrier, modulating inflammatory signaling, and stimulating cellular regeneration.
- Brand names
- ASCE+CELLTWEETEXOMAGEExosome Regenerative Complex
- Other names
- ExoSCRTstem cell-derived exosomesExoCoBio exosomes
02
Targets
Cer (Ceramide)
Beyond the preview
Go deeper on ExoSCRT Exosome.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ExoSCRT Exosome.